Search results
Results from the WOW.Com Content Network
In 1994, the Revised European-American Lymphoma (REAL) classification applied immunophenotypic and genetic features in identifying distinct clinicopathologic entities among all the lymphomas except Hodgkin lymphoma. [41] For coding purposes, the ICD-O (codes 9590–9999) [42] and ICD-10 (codes C81-C96) [43] are available.
Dementia due to Pick's disease: Coded 290.10 in the DSM-IV. 294.8: Dementia NOS: 294.xx: Dementia of the Alzheimer's type, with early onset: Coded 290.xx in the DSM-IV. 290.10: Dementia of the Alzheimer's type, with early onset, uncomplicated: Included only in the DSM-IV. 294.11: Dementia of the Alzheimer's type, with early onset, with ...
The DSM-5 (2013), the current version, also features ICD-9-CM codes, listing them alongside the codes of Chapter V of the ICD-10-CM. On 1 October 2015, the United States health care system officially switched from the ICD-9-CM to the ICD-10-CM. [1] [2] The DSM is the authoritative reference work in diagnosing mental disorders in the world.
The International Classification of Diseases for Oncology (ICD-O) is a domain-specific extension of the International Statistical Classification of Diseases and Related Health Problems for tumor diseases. This classification is widely used by cancer registries. It is currently in its third revision (ICD-O-3). ICD-10 includes a list of ...
Nodular sclerosing Hodgkin lymphoma ("NSHL") or Nodular sclerosis is a form of Hodgkin's lymphoma [1] that is the most common subtype of HL in developed countries. It affects females slightly more than males and has a median age of onset at ~28 years.
Angioimmunoblastic T-cell lymphoma; Extranodal natural killer/T-cell lymphoma, nasal type; Enteropathy type T-cell lymphoma; Subcutaneous panniculitis-like T-cell lymphoma; Anaplastic large cell lymphoma; Peripheral T-cell lymphoma not otherwise specified; In ICD-10, cutaneous T-cell lymphomas are classified separately.
Primary central nervous system lymphoma (PCNSL), also termed primary diffuse large B-cell lymphoma of the central nervous system (DLBCL-CNS), [2] is a primary intracranial tumor appearing mostly in patients with severe immunodeficiency (typically patients with AIDS). It is a subtype and one of the most aggressive of the diffuse large B-cell ...
The use of rituximab has been established for the treatment of B-cell–derived hematologic malignancies, including follicular lymphoma (FL) and diffuse large B-cell lymphoma (DLBCL). [ 7 ] In addition to cure-directed treatment, people can benefit from self-care to manage symptoms.